Clinical Trials Browser

Completed × Observational × Acute Kidney Injury × Clear all

NCT06549634 2026-02-27

Biomarkers of AKI in Patients Receiving Daratumumab

GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

NCT07114276 2026-01-09

Prospective Validation of Machine Learning Model to Predict Platinum Induced Nephrotoxicity in Cancer Patients

Acute Kidney Injury

NCT02358980 2025-06-25

KEEPER

GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

NCT06801405 2025-01-30

Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction

Neoplasms, Ureteral Obstruction, Urinary Tract Infections, Acute Kidney Injury

NCT06697613 2024-11-20

Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer

GenitourinaryGynecologic

Ovarian Neoplasms, Acute Kidney Injury

NCT04773080 2023-02-28

Incidence, Risk Factors and Consequences of Acute Kidney Injury in Patients Undergoing Esophageal Cancer Surgery

Postoperative Complications, Acute Kidney Injury

NCT02921828 2022-07-05

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

GenitourinaryPlasma cell

Sleepiness, Arrhythmias, Cardiac, Confusion, Consciousness Disorders, Dizziness, Fatigue, Heart Failure, Hypersensitivity, Infections, Jaundice, Liver Diseases, Multiple Myeloma, Peripheral Nervous System Diseases, Thromboembolism, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Acute Kidney Injury, Teratogenesis

NCT04341974 2020-04-14

CreaPeriop

Neoplasms, Acute Kidney Injury